TET2 c.5327C>T ;(p.S1776F)

Variant ID: 4-106196994-C-T

NM_001127208.2(TET2):c.5327C>T;(p.S1776F)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Deep Genomic Sequencing of Bladder Urothelial Carcinoma in Southern Chinese Patients: A Single-Center Study.

Frontiers In Oncology
Li, Dong-Yang DY; Yang, Fei F; Liao, Wei-Qiang WQ; Zhou, Xiang-Fu XF; Li, Wen-Biao WB; Cai, Jia-Rong JR; Liu, Bo-Long BL; Luo, Yun Y; Zhan, Hai-Lun HL
Publication Date: 2021

Variant appearance in text: TET2: 5327C>T
PubMed Link: 34055593
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
  • Table_1.xlsx, sheet 1
View BVdb publication page



Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.

Esmo Open
Cardone, Claudia C; Martinelli, Erika E; Troiani, Teresa T; Sforza, Vincenzo V; Avallone, Antonio A; Nappi, Anna A; Montesarchio, Vincenzo V; Andreozzi, Francesca F; Biglietto, Maria M; Calabrese, Filomena F; Bordonaro, Roberto R; Cordio, Stefano S; Bregni, Giacomo G; Febbraro, Antonio A; Garcia-Carbonero, Rocio R; Feliu, Jaime J; Cervantes, Andrés A; Ciardiello, Fortunato F
Publication Date: 2019

Variant appearance in text: TET2: S1776F
PubMed Link: 31555481
Variant Present in the following documents:
  • Main text
  • esmoopen-2019-000519.pdf
View BVdb publication page